Assessing efficacy and safety of genome EDITing approaches for Sickle Cell Disease

Información del proyecto

EDITSCD

Identificador del acuerdo de subvención: 101057659

DOI 10.3030/101057659

Fecha de la firma de la CE 24 Mayo 2022

Fecha de inicio 1 Septiembre 2022

Fecha de finalización 31 Agosto 2027

Financiado con arreglo a

• Health

Coste total € 6 532 000,00

Aportación de la UE € 6 532 000,00

Coordinado por

IMAGINE INSTITUT DES MALADIES GENETIQUES NECKER ENFANTS MALADES FONDATION
France

Resultado final

Documents, reports (2)

Data Management Plan 2

We will revise the data management plan (see paragraph 1.2.6) at month 18

Data Management Plan 1

A document describing the data management plan (see paragraph 1.2.6) will be produced and provided at month 6

Websites, patent fillings, videos etc. (1)

Project website and logo

A web page will be created in English for information of patients, families, patient organizations, the general public, health care providers, financial actors on the aims and progress of the project.

Publicaciones

Peer reviewed articles (1)

Clinical genome editing to treat sickle cell disease—A brief update

Autores: Parinaz Zarghamian; Julia Klermund; Toni Cathomen
Publicado en: Crossref, 2023, ISSN 2296-858X
Editor: Frontiers in Medecine
DOI: 10.3389/fmed.2022.1065377